US Stock MarketDetailed Quotes

Kiora Pharmaceuticals (KPRX)

Watchlist
  • 2.000
  • +0.020+1.01%
Trading Mar 9 11:45 ET
7.36MMarket Cap-0.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiora Pharmaceuticals (KPRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
16M
0
0
0
16M
0
0
Operating revenue
--0
--0
--0
--16M
--0
--0
--0
--16M
--0
--0
Cost of revenue
Gross profit
Operating expense
-6.77%2.52M
-6.86%2.26M
-26.34%2.06M
19.90%10.42M
25.80%2.51M
7.89%2.7M
-2.60%2.42M
63.38%2.79M
-25.90%8.69M
-44.96%1.99M
Selling and administrative expenses
4.55%1.44M
-11.97%1.35M
14.88%1.49M
18.85%5.54M
50.69%1.33M
-2.46%1.38M
40.16%1.54M
2.13%1.3M
-43.67%4.66M
-68.30%880.55K
-General and administrative expense
4.55%1.44M
-11.97%1.35M
14.88%1.49M
18.85%5.54M
50.69%1.33M
-2.46%1.38M
40.16%1.54M
2.13%1.3M
-43.67%4.66M
-68.30%880.55K
Research and development costs
-18.64%1.07M
-0.23%904.57K
-62.12%565.76K
21.60%4.9M
6.08%1.18M
21.40%1.32M
-34.87%906.68K
240.80%1.49M
16.76%4.03M
32.08%1.11M
Other operating expenses
----
----
-931.80%-1.97M
---20K
--0
----
---20K
---190.55K
----
----
Operating profit
6.77%-2.52M
6.86%-2.26M
-115.56%-2.06M
164.22%5.58M
-25.80%-2.51M
-7.89%-2.7M
2.60%-2.42M
873.53%13.21M
25.90%-8.69M
44.96%-1.99M
Net non-operating interest income expense
-18.89%201.82K
-34.16%225.24K
24.02%276.63K
656.13%1.23M
1,113.66%417.41K
398.56%248.84K
658.76%342.1K
566.51%223.05K
237.23%162.86K
-11.76%34.39K
Non-operating interest income
-18.89%201.82K
-34.16%225.24K
24.02%276.63K
620.07%1.25M
864.00%438.86K
398.56%248.84K
658.76%342.1K
566.51%223.05K
205.83%173.99K
-4.31%45.53K
Non-operating interest expense
----
----
----
92.65%21.45K
----
----
----
----
29.46%11.13K
----
Other net income (expense)
276.08%1.7M
-66.31%-231.33K
-1,538.52%-291.45K
70.42%-1.15M
68.38%-69.71K
70.90%-963.94K
17.94%-139.1K
110.43%20.26K
-93.08%-3.9M
-122.75%-220.49K
Special income (charges)
290.38%1.72M
-14.59%-137.77K
-2,356.78%-275.19K
69.97%-1.18M
-7.54%-166.51K
73.55%-904.01K
16.28%-120.23K
105.84%12.19K
-578.62%-3.93M
-115.66%-154.83K
-Less：Restructuring and merger&acquisition
-55.89%-1.72M
14.59%137.77K
2,356.78%275.19K
-147.05%-937.47K
-53.75%58.48K
-172.95%-1.1M
-16.28%120.23K
-105.84%-12.19K
241.98%1.99M
112.84%126.45K
-Less:Impairment of capital assets
----
----
----
--104.17K
----
----
----
----
----
----
-Write off
--0
----
----
5.44%2.01M
--0
5.44%2.01M
----
----
--1.9M
--0
-Gain on sale of property,plant,equipment
----
----
----
86.40%-3.86K
----
----
----
----
-773.93%-28.38K
----
Other non- operating income (expenses)
60.44%-23.71K
-396.03%-93.56K
-301.50%-16.25K
-9.60%26.07K
247.44%96.8K
-156.69%-59.93K
27.14%-18.86K
-45.00%8.07K
298.93%28.84K
-234.17%-65.65K
Income before tax
81.94%-616.32K
-1.93%-2.26M
-115.39%-2.07M
145.56%5.66M
0.91%-2.16M
40.77%-3.41M
15.00%-2.22M
819.99%13.45M
9.29%-12.42M
16.59%-2.18M
Income tax
-643.13K
-112.06K
123.01K
2,186.35%2.07M
2.07M
0
0
0
179.92%90.32K
Net income
100.79%26.81K
3.11%-2.15M
-116.30%-2.19M
128.73%3.59M
-86.17%-4.22M
40.77%-3.41M
15.00%-2.22M
819.99%13.45M
7.88%-12.51M
9.20%-2.27M
Net income continuous Operations
100.79%26.81K
3.11%-2.15M
-116.30%-2.19M
128.73%3.59M
-86.17%-4.22M
40.77%-3.41M
15.00%-2.22M
819.99%13.45M
7.88%-12.51M
9.20%-2.27M
Minority interest income
Net income attributable to the parent company
100.79%26.81K
3.11%-2.15M
-116.30%-2.19M
128.73%3.59M
-86.17%-4.22M
40.77%-3.41M
15.00%-2.22M
819.99%13.45M
7.88%-12.51M
9.20%-2.27M
Preferred stock dividends
Other preferred stock dividends
0
0
0
530.99K
0
Net income attributable to common stockholders
100.79%26.81K
3.11%-2.15M
-116.30%-2.19M
127.56%3.59M
-86.17%-4.22M
45.77%-3.41M
15.00%-2.22M
819.99%13.45M
3.97%-13.04M
9.20%-2.27M
Basic earnings per share
101.23%0.01
-1.89%-0.54
-111.13%-0.52
103.84%0.93
56.60%-1.15
88.90%-0.81
92.59%-0.53
151.89%4.67
85.47%-24.25
78.83%-2.6497
Diluted earnings per share
101.23%0.01
-1.89%-0.54
-115.03%-0.52
103.59%0.87
56.60%-1.15
88.90%-0.81
92.59%-0.53
138.44%3.46
85.47%-24.25
78.83%-2.6497
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00016M00016M00
Operating revenue --0--0--0--16M--0--0--0--16M--0--0
Cost of revenue
Gross profit
Operating expense -6.77%2.52M-6.86%2.26M-26.34%2.06M19.90%10.42M25.80%2.51M7.89%2.7M-2.60%2.42M63.38%2.79M-25.90%8.69M-44.96%1.99M
Selling and administrative expenses 4.55%1.44M-11.97%1.35M14.88%1.49M18.85%5.54M50.69%1.33M-2.46%1.38M40.16%1.54M2.13%1.3M-43.67%4.66M-68.30%880.55K
-General and administrative expense 4.55%1.44M-11.97%1.35M14.88%1.49M18.85%5.54M50.69%1.33M-2.46%1.38M40.16%1.54M2.13%1.3M-43.67%4.66M-68.30%880.55K
Research and development costs -18.64%1.07M-0.23%904.57K-62.12%565.76K21.60%4.9M6.08%1.18M21.40%1.32M-34.87%906.68K240.80%1.49M16.76%4.03M32.08%1.11M
Other operating expenses ---------931.80%-1.97M---20K--0-------20K---190.55K--------
Operating profit 6.77%-2.52M6.86%-2.26M-115.56%-2.06M164.22%5.58M-25.80%-2.51M-7.89%-2.7M2.60%-2.42M873.53%13.21M25.90%-8.69M44.96%-1.99M
Net non-operating interest income expense -18.89%201.82K-34.16%225.24K24.02%276.63K656.13%1.23M1,113.66%417.41K398.56%248.84K658.76%342.1K566.51%223.05K237.23%162.86K-11.76%34.39K
Non-operating interest income -18.89%201.82K-34.16%225.24K24.02%276.63K620.07%1.25M864.00%438.86K398.56%248.84K658.76%342.1K566.51%223.05K205.83%173.99K-4.31%45.53K
Non-operating interest expense ------------92.65%21.45K----------------29.46%11.13K----
Other net income (expense) 276.08%1.7M-66.31%-231.33K-1,538.52%-291.45K70.42%-1.15M68.38%-69.71K70.90%-963.94K17.94%-139.1K110.43%20.26K-93.08%-3.9M-122.75%-220.49K
Special income (charges) 290.38%1.72M-14.59%-137.77K-2,356.78%-275.19K69.97%-1.18M-7.54%-166.51K73.55%-904.01K16.28%-120.23K105.84%12.19K-578.62%-3.93M-115.66%-154.83K
-Less：Restructuring and merger&acquisition -55.89%-1.72M14.59%137.77K2,356.78%275.19K-147.05%-937.47K-53.75%58.48K-172.95%-1.1M-16.28%120.23K-105.84%-12.19K241.98%1.99M112.84%126.45K
-Less:Impairment of capital assets --------------104.17K------------------------
-Write off --0--------5.44%2.01M--05.44%2.01M----------1.9M--0
-Gain on sale of property,plant,equipment ------------86.40%-3.86K-----------------773.93%-28.38K----
Other non- operating income (expenses) 60.44%-23.71K-396.03%-93.56K-301.50%-16.25K-9.60%26.07K247.44%96.8K-156.69%-59.93K27.14%-18.86K-45.00%8.07K298.93%28.84K-234.17%-65.65K
Income before tax 81.94%-616.32K-1.93%-2.26M-115.39%-2.07M145.56%5.66M0.91%-2.16M40.77%-3.41M15.00%-2.22M819.99%13.45M9.29%-12.42M16.59%-2.18M
Income tax -643.13K-112.06K123.01K2,186.35%2.07M2.07M000179.92%90.32K
Net income 100.79%26.81K3.11%-2.15M-116.30%-2.19M128.73%3.59M-86.17%-4.22M40.77%-3.41M15.00%-2.22M819.99%13.45M7.88%-12.51M9.20%-2.27M
Net income continuous Operations 100.79%26.81K3.11%-2.15M-116.30%-2.19M128.73%3.59M-86.17%-4.22M40.77%-3.41M15.00%-2.22M819.99%13.45M7.88%-12.51M9.20%-2.27M
Minority interest income
Net income attributable to the parent company 100.79%26.81K3.11%-2.15M-116.30%-2.19M128.73%3.59M-86.17%-4.22M40.77%-3.41M15.00%-2.22M819.99%13.45M7.88%-12.51M9.20%-2.27M
Preferred stock dividends
Other preferred stock dividends 000530.99K0
Net income attributable to common stockholders 100.79%26.81K3.11%-2.15M-116.30%-2.19M127.56%3.59M-86.17%-4.22M45.77%-3.41M15.00%-2.22M819.99%13.45M3.97%-13.04M9.20%-2.27M
Basic earnings per share 101.23%0.01-1.89%-0.54-111.13%-0.52103.84%0.9356.60%-1.1588.90%-0.8192.59%-0.53151.89%4.6785.47%-24.2578.83%-2.6497
Diluted earnings per share 101.23%0.01-1.89%-0.54-115.03%-0.52103.59%0.8756.60%-1.1588.90%-0.8192.59%-0.53138.44%3.4685.47%-24.2578.83%-2.6497
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.77%
Sample Name
Sample Code
 +1.62%
Sample Name
Sample Code
 +1.20%
4
NVIDIA
NVDA
+1.02%
5
Palo Alto Networks
PANW
+0.51%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +9.52%
Sample Name
Sample Code
 +8.77%
Sample Name
Sample Code
 +4.32%
4
Zai Lab
ZLAB
+3.75%
5
JD.com
JD
+3.66%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -